These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 7965777)

  • 1. (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
    Sullivan JP; Decker MW; Brioni JD; Donnelly-Roberts D; Anderson DJ; Bannon AW; Kang CH; Adams P; Piattoni-Kaplan M; Buckley MJ
    J Pharmacol Exp Ther; 1994 Nov; 271(2):624-31. PubMed ID: 7965777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
    J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epibatidine is a nicotinic analgesic.
    Qian C; Li T; Shen TY; Libertine-Garahan L; Eckman J; Biftu T; Ip S
    Eur J Pharmacol; 1993 Dec; 250(3):R13-4. PubMed ID: 8112391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties.
    Sullivan JP; Donnelly-Roberts D; Briggs CA; Anderson DJ; Gopalakrishnan M; Xue IC; Piattoni-Kaplan M; Molinari E; Campbell JE; McKenna DG; Gunn DE; Lin NH; Ryther KB; He Y; Holladay MW; Wonnacott S; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1997 Oct; 283(1):235-46. PubMed ID: 9336329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
    Marks MJ; Meinerz NM; Drago J; Collins AC
    Neuropharmacology; 2007 Sep; 53(3):390-405. PubMed ID: 17631923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand.
    Sullivan JP; Donnelly-Roberts D; Briggs CA; Anderson DJ; Gopalakrishnan M; Piattoni-Kaplan M; Campbell JE; McKenna DG; Molinari E; Hettinger AM; Garvey DS; Wasicak JT; Holladay MW; Williams M; Arneric SP
    Neuropharmacology; 1996 Jun; 35(6):725-34. PubMed ID: 8887981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The heterocyclic substituted pyridine derivative (+/-)-2-(-3-pyridinyl)-1-azabicyclo[2.2.2]octane (RJR-2429): a selective ligand at nicotinic acetylcholine receptors.
    Bencherif M; Schmitt JD; Bhatti BS; Crooks P; Caldwell WS; Lovette ME; Fowler K; Reeves L; Lippiello PM
    J Pharmacol Exp Ther; 1998 Mar; 284(3):886-94. PubMed ID: 9495846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist.
    Sacaan AI; Reid RT; Santori EM; Adams P; Correa LD; Mahaffy LS; Bleicher L; Cosford ND; Stauderman KA; McDonald IA; Rao TS; Lloyd GK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):373-83. PubMed ID: 8996218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice.
    Damaj MI; Fonck C; Marks MJ; Deshpande P; Labarca C; Lester HA; Collins AC; Martin BR
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1161-9. PubMed ID: 17371806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.
    Gerzanich V; Peng X; Wang F; Wells G; Anand R; Fletcher S; Lindstrom J
    Mol Pharmacol; 1995 Oct; 48(4):774-82. PubMed ID: 7476906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epibatidine: a nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: in vitro and in vivo evidence in rats.
    Sacaan AI; Menzaghi F; Dunlop JL; Correa LD; Whelan KT; Lloyd GK
    J Pharmacol Exp Ther; 1996 Feb; 276(2):509-15. PubMed ID: 8632316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine.
    Bonhaus DW; Bley KR; Broka CA; Fontana DJ; Leung E; Lewis R; Shieh A; Wong EH
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1199-203. PubMed ID: 7891333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current.
    Alkondon M; Albuquerque EX
    J Pharmacol Exp Ther; 1995 Aug; 274(2):771-82. PubMed ID: 7543571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
    Gopalakrishnan M; Monteggia LM; Anderson DJ; Molinari EJ; Piattoni-Kaplan M; Donnelly-Roberts D; Arneric SP; Sullivan JP
    J Pharmacol Exp Ther; 1996 Jan; 276(1):289-97. PubMed ID: 8558445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
    de Moura FB; McMahon LR
    Psychopharmacology (Berl); 2017 Mar; 234(5):781-792. PubMed ID: 28028600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
    Rousseau SJ; Jones IW; Pullar IA; Wonnacott S
    Neuropharmacology; 2005 Jul; 49(1):59-72. PubMed ID: 15992581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the nicotinic agonist (R,S)-3-pyridyl-1-methyl-2-(3-pyridyl)-azetidine (MPA) with nicotinic acetylcholine receptor subtypes expressed in cell lines and rat cortex.
    Zhang X; Gong ZH; Fasth KJ; Långström B; Nordberg A
    Neurochem Int; 1998; 32(5-6):435-41. PubMed ID: 9676742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography.
    Sihver W; Gillberg PG; Nordberg A
    Neuroscience; 1998 Aug; 85(4):1121-33. PubMed ID: 9681951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epibatidine, a potent analgetic and nicotinic agonist.
    Badio B; Daly JW
    Mol Pharmacol; 1994 Apr; 45(4):563-9. PubMed ID: 8183234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.